173 related articles for article (PubMed ID: 28934284)
1. Correlation of DAPK1 methylation and the risk of gastrointestinal cancer: A systematic review and meta-analysis.
Yuan W; Chen J; Shu Y; Liu S; Wu L; Ji J; Liu Z; Tang Q; Zhou Z; Cheng Y; Jiang B; Shu X
PLoS One; 2017; 12(9):e0184959. PubMed ID: 28934284
[TBL] [Abstract][Full Text] [Related]
2. Association between DAPK1 promoter methylation and cervical cancer: a meta-analysis.
Xiong J; Li Y; Huang K; Lu M; Shi H; Ma L; Luo A; Yang S; Lu Z; Zhang J; Yang L; Wang S
PLoS One; 2014; 9(9):e107272. PubMed ID: 25268905
[TBL] [Abstract][Full Text] [Related]
3. DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis.
Agodi A; Barchitta M; Quattrocchi A; Maugeri A; Vinciguerra M
PLoS One; 2015; 10(8):e0135078. PubMed ID: 26267895
[TBL] [Abstract][Full Text] [Related]
4. Association of Protein Expression and Methylation of DAPK1 with Clinicopathological Features in Invasive Ductal Carcinoma Patients from Kashmir.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Zargar MA
Asian Pac J Cancer Prev; 2019 Mar; 20(3):839-848. PubMed ID: 30912402
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of Death-Associated Protein Kinase (DAPK1) and its association with oral carcinogenesis - An experimental and meta-analysis study.
Jayaprakash C; Varghese VK; Bellampalli R; Radhakrishnan R; Ray S; Kabekkodu SP; Satyamoorthy K
Arch Oral Biol; 2017 Aug; 80():117-129. PubMed ID: 28412611
[TBL] [Abstract][Full Text] [Related]
6. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation and expression of DAPk1 in human hypopharyngeal squamous cell carcinoma.
Wei DM; Liu DY; Lei DP; Jin T; Wang J; Pan XL
Acta Otolaryngol; 2015 Jan; 135(1):70-8. PubMed ID: 25496179
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
Ng HY; Wan TS; So CC; Chim CS
J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
[TBL] [Abstract][Full Text] [Related]
9. Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker.
Giachelia M; Bozzoli V; D'Alò F; Tisi MC; Massini G; Maiolo E; Guidi F; Cupelli E; Martini M; Larocca LM; Voso MT; Leone G; Hohaus S
J Mol Diagn; 2014 Jul; 16(4):467-76. PubMed ID: 24814955
[TBL] [Abstract][Full Text] [Related]
10. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma.
Melchers LJ; Clausen MJ; Mastik MF; Slagter-Menkema L; van der Wal JE; Wisman GB; Roodenburg JL; Schuuring E
Epigenetics; 2015; 10(9):850-60. PubMed ID: 26213212
[TBL] [Abstract][Full Text] [Related]
11. Association between promoter methylation of DAPK gene and HNSCC: A meta-analysis.
Cai F; Xiao X; Niu X; Zhong Y
PLoS One; 2017; 12(3):e0173194. PubMed ID: 28249042
[TBL] [Abstract][Full Text] [Related]
12. Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis.
Jia W; Yu T; Cao X; An Q; Yang H
Medicine (Baltimore); 2016 Oct; 95(43):e5040. PubMed ID: 27787359
[TBL] [Abstract][Full Text] [Related]
13. DAPK promoter methylation status correlates with tumor metastasis and poor prognosis in patients with non-small cell lung cancer.
Zhang J; Yu XL; Zheng GF; Zhao F
Cancer Biomark; 2015; 15(5):609-17. PubMed ID: 26406950
[TBL] [Abstract][Full Text] [Related]
14. Development of a multiplex MethyLight assay for the detection of DAPK1 and SOX1 methylation in epithelial ovarian cancer in a north Indian population.
Kaur M; Singh A; Singh K; Gupta S; Sachan M
Genes Genet Syst; 2016 Nov; 91(3):175-181. PubMed ID: 27452040
[TBL] [Abstract][Full Text] [Related]
15. DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.
Dai L; Ma C; Zhang Z; Zeng S; Liu A; Tang S; Ren Q; Sun Y; Xu C
PLoS One; 2016; 11(12):e0167228. PubMed ID: 27907054
[TBL] [Abstract][Full Text] [Related]
16. Relationships between p16 gene promoter methylation and clinicopathologic features of colorectal cancer: a meta-analysis of 27 cohort studies.
Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
DNA Cell Biol; 2014 Oct; 33(10):729-38. PubMed ID: 24979649
[TBL] [Abstract][Full Text] [Related]
17. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis.
Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G
PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of DAPK1 hypermethylation in gliomas: A site-specific analysis.
Li X; Pu J; Liu J; Chen Y; Li Y; Hou P; Shi B; Yang Q
Pathol Res Pract; 2018 Jul; 214(7):940-948. PubMed ID: 29807777
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: a meta-analysis.
Li FF; Yang Y; Wang XL; Hong YY; Wang NF; Chen ZD
Tumour Biol; 2014 Jun; 35(6):6011-20. PubMed ID: 24659425
[TBL] [Abstract][Full Text] [Related]
20. BNIP3 and DAPK1 methylation in peripheral blood leucocytes are noninvasive biomarkers for gastric cancer.
Wang F; Hu D; Lou X; Wang Y; Wang L; Zhang T; Yan Z; Meng N; Zou Y
Gene; 2024 Mar; 898():148109. PubMed ID: 38142898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
